About Evoke Pharma, Inc
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California. Address: 420 Stevens Avenue, Solana Beach, CA, United States, 92075
Evoke Pharma, Inc News and around…
Latest news about Evoke Pharma, Inc (EVOK) common stock and company :
Research Study Among Patients Demonstrated Favorable Acceptance and Utilization of GIMOTISOLANA BEACH, Calif. and CHICAGO, May 18, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, and EVERSANA™, a leading provider of global commercial services to the life science industry, today announced positive findings from the first patient-centered survey related to GIMOTI. Following the series of market
SOLANA BEACH, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI (metoclopramide) nasal spray, today announced that its management team will present at the H.C. Wainwright Global Investment Conference being held at the Fontainebleau Miami Beach Hotel from May 23-26, 2022. The presentation will be virtual and will provide an overview of the comm
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! It's time for another busy day of trading as we dive into the biggest pre-market stock movers for Tuesday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
Gainers Bird Global, Inc. (NASDAQ: BRDS) rose 26.3% to $1.24 in pre-market trading after the company posted strong Q1 ...
Gainers Trevena (NASDAQ:TRVN) shares moved upwards by 13.3% to $0.23 during Friday's after-market session. The market value of their ...
Evoke Pharma (NASDAQ:EVOK) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM. Here's what investors need to know ...
Several sales growth indicators increased over Q4, 2021: New Prescribers up 41%; Product delivered to patients up 39%; Net Revenue increased by 16%; Prescriptions written up 22%SOLANA BEACH, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced its financial results for the first quarter ended March 31, 2022, and recent corporate developments. “We are encou
SOLANA BEACH, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company is scheduled to release its first quarter 2022 financial results on Tuesday, May 10, 2022, after the market closes. Management will host a conference call on Tuesday May 10, 2022, at 4:30 p.m. ET to discuss the results. The dial-in numbers for the conference call are (800) 891-3840 f
Gainers SoundHound AI, Inc. (NASDAQ: SOUN) rose 64.3% to $10.68 in pre-market trading after tumbling 13% on Friday. SoundHound had ...
Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired ...
Gainers Belite Bio Inc. ADR (NASDAQ: BLTE) shares surged 144.8% to $14.69. Belite Bio priced its 6 million ADS IPO at $6 per ...
Gainers Finch Therapeutics Group (NASDAQ:FNCH) stock increased by 55.7% to $3.27 during Friday's pre-market session. ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! It's the beginning of the end as we break down all of the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
Gainers Zymeworks Inc. (NASDAQ: ZYME) rose 40.3% to $6.97 in pre-market trading. Zymeworks 13D filing confirmed earlier reporting ...
Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its ...
Gainers Statera BioPharma (NASDAQ:STAB) stock moved upwards by 119.1% to $0.46 during Thursday's regular session. As ...
Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed ...
Gainers Cosmos Holdings (NASDAQ:COSM) shares rose 68.6% to $1.79 during Wednesday's regular session. Cosmos ...
Gainers Vivakor, Inc. (NASDAQ: VIVK) gained 154% to $4.3550 after the company announced it has signed a 10-year contract with ...
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) shares rose 100.9% to $2.13 in pre-market trading after jumping over 16% on Tuesday. ...
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product ...
U.S. stocks remained lower toward the end of trading, with the Dow Jones tumbling more than 500 points on Tuesday. The Dow traded ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Evoke Pharma is up an unbelievable 130% today on news of recently granted drug exclusivity. How high will EVOK stock soar? The post Why Is Evoke Pharma (EVOK) Stock Up 130% Today? appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
Gainers Evoke Pharma (NASDAQ:EVOK) stock moved upwards by 138.5% to $0.94 during Tuesday's regular session. As of ...
Yahoo Finance's Ines Ferre joins the Live show to break down how stocks are moving in midday trading.
TheFDA has granted new drug product exclusivitytoEvoke Pharma Inc's(NASDAQ: EVOK) Gimoti (metoclopramide) ...
Reinforces Company’s Robust Intellectual Property PortfolioSOLANA BEACH, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced that it has been granted new drug product exclusivity by the U.S. Food and Drug Administration (FDA) for GIMOTI (metoclopramide) nasal spray. Evoke now has exclusive marketing rights over a period of three (3) years from the origi
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron ...
Market access improves with approximately 5 million people in the Texas Medicaid patient networkSOLANA BEACH, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, announced today that GIMOTI® (metoclopramide) nasal spray a novel treatment solution for the treatment of symptoms associated with diabetic gastroparesis (DGP), has been added to the Texas Medicaid Preferred D
Gainers Kaleido Biosciences (NASDAQ:KLDO) stock increased by 10.3% to $0.32 during Thursday's after-market session. Today's trading ...
Evoke Pharma, Inc (EVOK) is a NASDAQ Common Stock listed in Common Stock, Drug Manufacturers-Specialty & Generic, Healthcare
